Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study

Background This post-marketing surveillance (PMS), observational, prospective, safety study evaluated the safety, tolerability, and long-term immunogenicity of prescribed usage of Darbepoetin alfa (DA-α, manufactured by Hetero Biopharma, Hyderabad, India) in Indian patients having chronic kidney dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Shubhadeep D, Bandi, Vamsi K, Reddy, Bala B, Thakur, Pankaj, Chary, Sreenivasa, Talluri, Leela, Kakkunnath, Sheejith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Nephrology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161703/
https://www.ncbi.nlm.nih.gov/pubmed/34079677
http://dx.doi.org/10.7759/cureus.14730

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161703/
https://www.ncbi.nlm.nih.gov/pubmed/34079677
http://dx.doi.org/10.7759/cureus.14730

Ejemplares similares